SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 8/5/2015 3:21:38 AM - Followers: 622 - Board type: Free - Posts Today: 6

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
The above link is kept updated.
http://www.zoominfo.com/p/Daniel-Jorgensen/1064701588
 

 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/

http://cellceutix.com/wp-content/uploads/2015/06/Cellceutix-Fact-Sheet-June-2015-flattened-1.pdf

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 
 

 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Special Profile Coming and 4 Analyst Reports 07/21/2015 07:00:00 AM
CTIX News: Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports 06/15/2015 07:00:00 AM
CTIX News: Special Profile & Four Companies Where Investors are Anticipating Success 06/03/2015 07:00:00 AM
CTIX News: *Special Analyst Alert* and 4 Companies that are Worth a Look 05/13/2015 07:00:00 AM
CTIX News: Quarterly Report (10-q) 05/11/2015 02:03:16 PM
PostSubject
#114702  Sticky Note Cellceutix Announces Ongoing Enrollment of Phase 2 Trial TOB 08/03/15 09:38:40 AM
#114611  Sticky Note Brilliant chart showing the true Cellceutix corporate development TOB 08/02/15 04:26:55 PM
#114061  Sticky Note There are details that will be outlined for BigKahuna 07/29/15 09:41:25 PM
#112962  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 07/24/15 02:10:27 PM
#111959  Sticky Note Cellceutix to Start Brilacidin Phase 3 Program in ABSSSI BigKahuna 07/20/15 07:41:11 AM
#87958  Sticky Note Cellceutix Reports Spleen Lesion 'Disappears' in Patient With starbuxsux 01/20/15 08:25:55 AM
#115069   Looks to me that we'll start seeing a BooDog 08/05/15 06:21:07 AM
#115068   "For a quick uplist they had to hold loanranger 08/05/15 03:21:38 AM
#115067   That is your response to my post?? Kindly Waverunner1 08/05/15 01:14:09 AM
#115066   Wrong again. We had a lower close only thefamilyman 08/05/15 12:58:34 AM
#115065   I don't think Leo and Ctix were pretending nerby 08/05/15 12:52:33 AM
#115064   I still own a ton of "this." CallMeCrazy 08/05/15 12:00:07 AM
#115063   You may want to check ur math. TheHound 08/04/15 11:52:49 PM
#115062   Well, that's CTIX at 14.00 to break even etradeedge 08/04/15 11:50:10 PM
#115061   And don't give it all back again this time! TheHound 08/04/15 11:42:01 PM
#115060   I've had a great year as well. Best TheHound 08/04/15 11:41:24 PM
#115059   Me too! The stock this replaced since it etradeedge 08/04/15 11:40:11 PM
#115058   I can understand where you're coming from in TheHound 08/04/15 11:20:16 PM
#115057   Used to own a ton of this and etradeedge 08/04/15 11:08:50 PM
#115056   Extraordinary returns follow extraordinary discipline. TheHound 08/04/15 10:38:18 PM
#115055   Not much to say about the recent sell JSN2000 08/04/15 10:28:03 PM
#115054   I agree. And, this stock has been Ebuilder 08/04/15 10:10:47 PM
#115053   It's very discouraging everything seems to be in green is good 08/04/15 09:51:43 PM
#115052   I mean no negative news to explain the WHcraftsman 08/04/15 09:45:56 PM
#115051   Yeah it's been ridiculous. With nothing but good WHcraftsman 08/04/15 09:45:05 PM
#115050   No news for ctix? scottsmith 08/04/15 09:44:43 PM
#115049   Wow this has certainly been one of the green is good 08/04/15 09:30:05 PM
#115047   Many small cap bios I follow are very WHcraftsman 08/04/15 09:17:09 PM
#115045   Tomorrow's a big PR day. Let's see what TheHound 08/04/15 08:56:26 PM
#115042   Where you been DJ??? eventhelosers 08/04/15 08:45:28 PM
#115041   Not suggesting anything, just trying to define "lots." Ebuilder 08/04/15 08:41:35 PM
#115038   Pretty sure CTIX submitted an application to uplist eventhelosers 08/04/15 08:35:42 PM
#115037   well lets just say in the next 12-18 TimetoRetire 08/04/15 08:33:50 PM
#115036   Apparently nothing even close to as good as Loose Lips 08/04/15 08:29:57 PM
#115035   Not sure you can compare the two drugs Ebuilder 08/04/15 08:26:42 PM
#115034   Play devil's advocate from a scientific view. I TheMonolith 08/04/15 08:26:17 PM
#115033   If I read one more ihub email from scottsmith 08/04/15 08:25:03 PM
#115032   Or the xfer of wealth to that other guy eventhelosers 08/04/15 08:22:54 PM
#115031   Kevetrin phase 1 trial reminds me of the Dr Jerry 08/04/15 08:20:51 PM
#115030   LoL.... Ebuilder 08/04/15 08:20:23 PM
#115028   Define "lots" Ebuilder 08/04/15 08:19:32 PM
#115025   It will be a true slap in the TimetoRetire 08/04/15 08:13:11 PM
#115023   Keeping shareholders in the dark regarding uplist requirements TheHound 08/04/15 07:49:09 PM
#115022   True. Not with our pathetic volume. scottsmith 08/04/15 07:44:06 PM
#115021   Pretending to be ready to go to Nasdaq noretreat 08/04/15 07:40:02 PM
#115020   Doesn't sound far fetched to me Ebuilder 08/04/15 07:38:45 PM
#115019   I tend to agree. That said, he wouldn't TheHound 08/04/15 07:38:14 PM
#115018   The lower the volume the larger the effect. TheHound 08/04/15 07:37:38 PM
#115017   Aruda not dumping. He knows what he owns... scottsmith 08/04/15 07:36:41 PM
#115016   The volume seems awfully low for that. But maybe. TheDane 08/04/15 07:35:51 PM
#115015   Aruda dumping shares from Menon and Aspire dumping TheHound 08/04/15 07:33:48 PM
#115014   Today's closing price means absolutely nothing to me. sox040713 08/04/15 07:23:49 PM
#115013   Oh great another email. scottsmith 08/04/15 07:09:39 PM
#115011   FINRA short sales of CTIX AlanC 08/04/15 07:07:05 PM
#115010   So what about Orphan Designation by a third eventhelosers 08/04/15 07:04:39 PM
#115009   Just a reminder on what Leo said about sox040713 08/04/15 07:03:53 PM
PostSubject